McNeil Ads Defend Tylenol As Competitors "Demonize" Acetaminophen

The recent FDA advisory panel recommendation to restrict acetaminophen put Tylenol maker McNeil Consumer Healthcare on the defensive as competitors began to "demonize" the ingredient in ads in an effort to steal the firm's market share

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet